DigitalBridge to Acquire ArcLight in 1 Billion Power Infrastructure Deal Tech Media Telecom Roundup Market Talks Focus on AI and Fintech Developments Saudi Arabias Vision 2030 Spending Spree Faces Reality Check DR Congo World Cup Squad Faces 21Day Isolation Due to Ebola Concerns Potential Impact on Tournament Participation and Sports Economics Principal Financial Group Faces Analyst Uncertainty Amid Retirement Market Shifts Fraudsters Forged Paperwork Too Modern Foils Fake Statue Scheme at Sothebys Teradyne Q1 2026 Earnings Strong EPS Beat Driven by Robust Demand in Semiconductor Test CNMD Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline Cheetah Mobile CMCM Q4 2025 Earnings Loss Per ADS of 110 Stock Declines 35 XOMAO Q1 2026 Earnings Preferred Stock Reports Negative EPS Surprise Amid Quiet Quarter ASM Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency and Metal Prices CNTN Q4 2023 Earnings Significant Loss Beat as Strategic Initiatives Gain Traction Eagle Point Credit Notes ECCW Steady Near Par as FixedIncome Market Consolidates UDR Inc Holds Steady Near Support as REIT Sector Navigates Rate Uncertainty Evolent Health Inc EVH Surges 286 Testing Key Resistance Amid Renewed Buying Interest Calidi Biotherapeutics CLDI Declines Slightly Approaching Key Support at 016 Ioneer Ltd IONR Shows Strength Up 218 as Lithium Developer Approaches Key Resistance Oxford Industries Q1 2026 Earnings Earnings Miss Widens Despite Stock Rally PENG Q1 2026 Earnings Strong EPS Beat Drives 9 Surge Community Healthcare Trust CHCT Q1 2026 Earnings Massive EPS Beat Masks Continued Market Caution ICL Q1 2026 Earnings EPS Beats Estimates by 1458 Stock Slightly Down MTNB Q4 2024 Earnings Narrowing Losses Surprise as Biotech Advances Pipeline Without Revenue SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development Trump Advises Caution in Iran Negotiations as Strait of Hormuz Reopening Considered UFPI Q1 2026 Earnings EPS Misses Estimates Amid Soft Demand and Margin Compression Inhibikase Therapeutics IKT Holds Near Support Amid Modest Gains